Yifan Pharmaceutical announced that on July 16, the company repurchased 5 million shares through centralized competitive trading for the first time, accounting for 0.41% of its current total share capital, with a total transaction amount of 53.9436 million yuan. The highest repurchase price was 11.04 yuan per share, the lowest was 10.54 yuan per share, and the average transaction price was 10.79 yuan per share. According to the previously approved repurchase plan, the company intends to use its own or self-raised funds to repurchase shares for cancellation and reduction of registered capital, with a total repurchase amount of no less than 100 million yuan and no more than 120 million yuan, a repurchase price not exceeding 17.45 yuan per share, and a repurchase period of 12 months from the date of approval by the shareholders' meeting.
Yifan Xinfu Pharmaceutical Co LtdCompany repurchased shares for cancellation, signaling capital return to shareholders and support for stock price.